Global Medical Transdermal Drug Delivery System Market Growth 2025-2031

Publication ID:

LPI06261480

Publication Date:

June 13, 2025

Pages:

141

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Medical Transdermal Drug Delivery System market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
A transdermal drug delivery system (TTS), or transdermal patch, is a way for drugs to be absorbed into the body through the skin. TTS is a very useful form of drug delivery with many advantages. One is that when the patch is attached to the skin, drug administration can be visually confirmed. Additionally, these formulations are designed to control the rate of drug absorption, helping to maintain blood levels over a longer period of time.
United States market for Medical Transdermal Drug Delivery System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Medical Transdermal Drug Delivery System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Medical Transdermal Drug Delivery System is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Medical Transdermal Drug Delivery System players cover 3M, Hisamitsu, Mylan, GSK, Novartis, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淢edical Transdermal Drug Delivery System Industry Forecast鈥� looks at past sales and reviews total world Medical Transdermal Drug Delivery System sales in 2024, providing a comprehensive analysis by region and market sector of projected Medical Transdermal Drug Delivery System sales for 2025 through 2031. With Medical Transdermal Drug Delivery System sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Medical Transdermal Drug Delivery System industry.
This Insight Report provides a comprehensive analysis of the global Medical Transdermal Drug Delivery System landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Medical Transdermal Drug Delivery System portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Medical Transdermal Drug Delivery System market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Medical Transdermal Drug Delivery System and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Medical Transdermal Drug Delivery System.
This report presents a comprehensive overview, market shares, and growth opportunities of Medical Transdermal Drug Delivery System market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Others
Segmentation by Application:
Prescription Drugs
Non-prescription Drugs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
3M
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Laboratoires Genevrier
Haw Par
Nichiban
Mentholatum
Key Questions Addressed in this Report
What is the 10-year outlook for the global Medical Transdermal Drug Delivery System market?
What factors are driving Medical Transdermal Drug Delivery System market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Medical Transdermal Drug Delivery System market opportunities vary by end market size?
How does Medical Transdermal Drug Delivery System break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Medical Transdermal Drug Delivery System Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Medical Transdermal Drug Delivery System by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Medical Transdermal Drug Delivery System by Country/Region, 2020, 2024 & 2031
2.2 Medical Transdermal Drug Delivery System Segment by Type
2.2.1 Fentanyl
2.2.2 Nitroglycerin
2.2.3 Estradiol
2.2.4 Nicotine
2.2.5 Others
2.3 Medical Transdermal Drug Delivery System Sales by Type
2.3.1 Global Medical Transdermal Drug Delivery System Sales Market Share by Type (2020-2025)
2.3.2 Global Medical Transdermal Drug Delivery System Revenue and Market Share by Type (2020-2025)
2.3.3 Global Medical Transdermal Drug Delivery System Sale Price by Type (2020-2025)
2.4 Medical Transdermal Drug Delivery System Segment by Application
2.4.1 Prescription Drugs
2.4.2 Non-prescription Drugs
2.5 Medical Transdermal Drug Delivery System Sales by Application
2.5.1 Global Medical Transdermal Drug Delivery System Sale Market Share by Application (2020-2025)
2.5.2 Global Medical Transdermal Drug Delivery System Revenue and Market Share by Application (2020-2025)
2.5.3 Global Medical Transdermal Drug Delivery System Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Medical Transdermal Drug Delivery System Breakdown Data by Company
3.1.1 Global Medical Transdermal Drug Delivery System Annual Sales by Company (2020-2025)
3.1.2 Global Medical Transdermal Drug Delivery System Sales Market Share by Company (2020-2025)
3.2 Global Medical Transdermal Drug Delivery System Annual Revenue by Company (2020-2025)
3.2.1 Global Medical Transdermal Drug Delivery System Revenue by Company (2020-2025)
3.2.2 Global Medical Transdermal Drug Delivery System Revenue Market Share by Company (2020-2025)
3.3 Global Medical Transdermal Drug Delivery System Sale Price by Company
3.4 Key Manufacturers Medical Transdermal Drug Delivery System Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Medical Transdermal Drug Delivery System Product Location Distribution
3.4.2 Players Medical Transdermal Drug Delivery System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Medical Transdermal Drug Delivery System by Geographic Region
4.1 World Historic Medical Transdermal Drug Delivery System Market Size by Geographic Region (2020-2025)
4.1.1 Global Medical Transdermal Drug Delivery System Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Medical Transdermal Drug Delivery System Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Medical Transdermal Drug Delivery System Market Size by Country/Region (2020-2025)
4.2.1 Global Medical Transdermal Drug Delivery System Annual Sales by Country/Region (2020-2025)
4.2.2 Global Medical Transdermal Drug Delivery System Annual Revenue by Country/Region (2020-2025)
4.3 Americas Medical Transdermal Drug Delivery System Sales Growth
4.4 APAC Medical Transdermal Drug Delivery System Sales Growth
4.5 Europe Medical Transdermal Drug Delivery System Sales Growth
4.6 Middle East & Africa Medical Transdermal Drug Delivery System Sales Growth
5 Americas
5.1 Americas Medical Transdermal Drug Delivery System Sales by Country
5.1.1 Americas Medical Transdermal Drug Delivery System Sales by Country (2020-2025)
5.1.2 Americas Medical Transdermal Drug Delivery System Revenue by Country (2020-2025)
5.2 Americas Medical Transdermal Drug Delivery System Sales by Type (2020-2025)
5.3 Americas Medical Transdermal Drug Delivery System Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Medical Transdermal Drug Delivery System Sales by Region
6.1.1 APAC Medical Transdermal Drug Delivery System Sales by Region (2020-2025)
6.1.2 APAC Medical Transdermal Drug Delivery System Revenue by Region (2020-2025)
6.2 APAC Medical Transdermal Drug Delivery System Sales by Type (2020-2025)
6.3 APAC Medical Transdermal Drug Delivery System Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Medical Transdermal Drug Delivery System by Country
7.1.1 Europe Medical Transdermal Drug Delivery System Sales by Country (2020-2025)
7.1.2 Europe Medical Transdermal Drug Delivery System Revenue by Country (2020-2025)
7.2 Europe Medical Transdermal Drug Delivery System Sales by Type (2020-2025)
7.3 Europe Medical Transdermal Drug Delivery System Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Medical Transdermal Drug Delivery System by Country
8.1.1 Middle East & Africa Medical Transdermal Drug Delivery System Sales by Country (2020-2025)
8.1.2 Middle East & Africa Medical Transdermal Drug Delivery System Revenue by Country (2020-2025)
8.2 Middle East & Africa Medical Transdermal Drug Delivery System Sales by Type (2020-2025)
8.3 Middle East & Africa Medical Transdermal Drug Delivery System Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Medical Transdermal Drug Delivery System
10.3 Manufacturing Process Analysis of Medical Transdermal Drug Delivery System
10.4 Industry Chain Structure of Medical Transdermal Drug Delivery System
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Medical Transdermal Drug Delivery System Distributors
11.3 Medical Transdermal Drug Delivery System Customer
12 World Forecast Review for Medical Transdermal Drug Delivery System by Geographic Region
12.1 Global Medical Transdermal Drug Delivery System Market Size Forecast by Region
12.1.1 Global Medical Transdermal Drug Delivery System Forecast by Region (2026-2031)
12.1.2 Global Medical Transdermal Drug Delivery System Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Medical Transdermal Drug Delivery System Forecast by Type (2026-2031)
12.7 Global Medical Transdermal Drug Delivery System Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 3M
13.1.1 3M Company Information
13.1.2 3M Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.1.3 3M Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 3M Main Business Overview
13.1.5 3M Latest Developments
13.2 Hisamitsu
13.2.1 Hisamitsu Company Information
13.2.2 Hisamitsu Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.2.3 Hisamitsu Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Hisamitsu Main Business Overview
13.2.5 Hisamitsu Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.3.3 Mylan Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 GSK
13.4.1 GSK Company Information
13.4.2 GSK Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.4.3 GSK Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 GSK Main Business Overview
13.4.5 GSK Latest Developments
13.5 Novartis
13.5.1 Novartis Company Information
13.5.2 Novartis Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.5.3 Novartis Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Novartis Main Business Overview
13.5.5 Novartis Latest Developments
13.6 Teve (Actavis)
13.6.1 Teve (Actavis) Company Information
13.6.2 Teve (Actavis) Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.6.3 Teve (Actavis) Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Teve (Actavis) Main Business Overview
13.6.5 Teve (Actavis) Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.7.3 Johnson & Johnson Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Lohmann
13.8.1 Lohmann Company Information
13.8.2 Lohmann Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.8.3 Lohmann Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lohmann Main Business Overview
13.8.5 Lohmann Latest Developments
13.9 Teikoku Seiyaku
13.9.1 Teikoku Seiyaku Company Information
13.9.2 Teikoku Seiyaku Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.9.3 Teikoku Seiyaku Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Teikoku Seiyaku Main Business Overview
13.9.5 Teikoku Seiyaku Latest Developments
13.10 Bayer
13.10.1 Bayer Company Information
13.10.2 Bayer Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.10.3 Bayer Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Bayer Main Business Overview
13.10.5 Bayer Latest Developments
13.11 Lingrui
13.11.1 Lingrui Company Information
13.11.2 Lingrui Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.11.3 Lingrui Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Lingrui Main Business Overview
13.11.5 Lingrui Latest Developments
13.12 Sanofi
13.12.1 Sanofi Company Information
13.12.2 Sanofi Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.12.3 Sanofi Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Sanofi Main Business Overview
13.12.5 Sanofi Latest Developments
13.13 Qizheng
13.13.1 Qizheng Company Information
13.13.2 Qizheng Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.13.3 Qizheng Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Qizheng Main Business Overview
13.13.5 Qizheng Latest Developments
13.14 Endo
13.14.1 Endo Company Information
13.14.2 Endo Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.14.3 Endo Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Endo Main Business Overview
13.14.5 Endo Latest Developments
13.15 Laboratoires Genevrier
13.15.1 Laboratoires Genevrier Company Information
13.15.2 Laboratoires Genevrier Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.15.3 Laboratoires Genevrier Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Laboratoires Genevrier Main Business Overview
13.15.5 Laboratoires Genevrier Latest Developments
13.16 Haw Par
13.16.1 Haw Par Company Information
13.16.2 Haw Par Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.16.3 Haw Par Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Haw Par Main Business Overview
13.16.5 Haw Par Latest Developments
13.17 Nichiban
13.17.1 Nichiban Company Information
13.17.2 Nichiban Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.17.3 Nichiban Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.17.4 Nichiban Main Business Overview
13.17.5 Nichiban Latest Developments
13.18 Mentholatum
13.18.1 Mentholatum Company Information
13.18.2 Mentholatum Medical Transdermal Drug Delivery System Product Portfolios and Specifications
13.18.3 Mentholatum Medical Transdermal Drug Delivery System Sales, Revenue, Price and Gross Margin (2020-2025)
13.18.4 Mentholatum Main Business Overview
13.18.5 Mentholatum Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂